Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis
Article 2017 en
Authors
II
Ireny Iskandar
DA
Darren M. Ashcroft
RW
Richard B. Warren
Abstract
1 min read
In routine clinical practice biological therapies produce marked improvement in HRQoL, which is influenced by the choice of biological therapy, baseline impairment in HRQoL, lifestyle characteristics and comorbidities. These findings should help inform selection of optimal biological therapy for patients related to improvements in HRQoL.
Wolfram Sterry, Juliet N. Barker, Wolf‐Henning Boehncke, J.D. Bos, Sergio Chimenti, Enno Christophers, M. de la Brassinne, Christopher Em Griffiths, Andreas Katsambas, Knud Kragballe, Charles Lynde, Alan Menter, J.‐P. Ortonne, Kim Papp, Jörg C. Prinz, Berthold Rzany, J.R. Rönnevig, J.‐H. Saurat, Mona Ståhle, Fernando Stengel, P.C.M. van de Kerkhof, John J. Voorhees
Jake Thompson, Julia Lai‐Kwon, Rachael L. Morton, Alexander Guminski, Maria Gonzalez, Victoria Atkinson, Shahneen Sandhu, Michael P. Brown, Alexander M. Menzies, Grant A. McArthur, Serigne Lo, Georgina V. Long, Iris Bartula
Nophar Geifman, Narges Azadbakht, J. Zeng, Toby Wilkinson, Nick Dand, Iain Buchan, Deborah Stocken, Paola Di Meglio, Richard B. Warren, Juliet N. Barker, Nick J. Reynolds, Michael R. Barnes, Catherine Smith, Christopher Em Griffiths, Niels Peek
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.